Stock Chart

LVTX

$1.74 -3.87%
Score: 66.8 BUY
Vol: 2.35x (vs SPY: 1.8x | vs QQQ: 1.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LVTX - LAVA Therapeutics N.V. Ordinary Shares

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Key Statistics

Market Cap $46M

This LVTX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LVTX's price movements with trendlines, gamma walls, and key support/resistance levels.